69 Cancer Treatment Flashcards
1
Q
A monoclonal antibody that targets the EGFR A. Rituximab B. Bevacizumab C. Trastuzuman D. Panitumumab
A
D. Panitumumab
2
Q
FDA approved molecularly targeted drug used for breast cancer that act as competitive inhibitos of ATP binding site of Her2? A. Erlotinib B. Afitinib C. Imatinib D. Lapatinib
A
A. Erlotinib
3
Q
Monoclonal antibody targets VEGF A. Rituximab B. Bevacizumab C. Trastuzuman D. Panitumumab
A
B. Bevacizumab
4
Q
A JAK1 molecular targeted drug that acts by a competitive inhibitor of tyrosine kinase used for the treatment with myelofibrosis A. Ruxolitinib B. Lenatinib C. Erlotinib D. Sunitinib
A
D. Sunitinib
5
Q
A feature that best distinguishing a neoplasm from a granuloma is that neoplasm is? A. Rapid increase in size B. Sensitive to radiation/ chemotherapy C. Necrosis D. Uncontrolled growth
A
D. Uncontrolled growth
6
Q
Primary treatment for locoregionally advanced head and neck carcinoma consist of A. Surgery B. Radiation therapy C. Chemoradiation therapy D. All of the above
A
D. All of the above
